{
    "eid": "2-s2.0-84953255967",
    "title": "Neurological Response to cART vs. cART plus integrase inhibitor and ccr5 antagonist initiated during acute HIV",
    "cover-date": "2015-11-10",
    "subject-areas": [
        {
            "$": "Multidisciplinary",
            "@code": "1000"
        }
    ],
    "keywords": [],
    "authors": [
        "Victor G. Valcour"
    ],
    "citedby-count": 24,
    "ref-count": 26,
    "ref-list": [
        "Central nervous system viral invasion and inflammation during acute HIV infection",
        "Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden",
        "Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection",
        "Absence of Cerebrospinal Fluid Signs of Neuronal Injury before and after Immediate Antiretroviral Therapy in Acute HIV Infection",
        "The neuropathogenesis of AIDS",
        "HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Na\u00efve Patients",
        "Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: Reduced replicating and latent SIV in the brain",
        "In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells",
        "Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms",
        "Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-associated neurocognitive disease (HAND)",
        "Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells",
        "HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects",
        "Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: A randomized 48-week study",
        "Raltegravir central nervous system tolerability in clinical practice: Results from a multicenter observational study",
        "Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1",
        "Neurologic complications of HIV disease and their treatment.",
        "Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection",
        null,
        "Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders",
        "Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection",
        "Change in Brain Magnetic Resonance Spectroscopy after Treatment during Acute HIV Infection",
        "Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes",
        "Journal of the Royal Statistical Society Series B (Methodological",
        "Astrocyte and Microglial Activation in Acute and Chronic HIV Pre-and Post-CART",
        "Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy",
        "Raltegravir treatment intensification does not alter cerebrospinal fluid hiv-1 infection or immunoactivation in subjects on suppressive therapy"
    ],
    "affiliation": [
        {
            "affiliation-city": "San Francisco",
            "affilname": "UCSF School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Thai Red Cross Agency",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "San Francisco",
            "affilname": "University of California, San Francisco",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New Haven",
            "affilname": "Yale School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Armed Forces Research Institute of Medical Sciences, Thailand",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rockville",
            "affilname": "HJF",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Silver Spring",
            "affilname": "Walter Reed Army Institute of Research",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Pasadena",
            "affilname": "Huntington Medical Research Institutes",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "National Institutes of Health",
        "National Institutes of Health",
        "National Institute of Mental Health",
        "National Institute of Mental Health"
    ]
}